Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
12,250,632
-
Share change
-
+680,226
-
Total reported value
-
$2,761,923,747
-
Put/Call ratio
-
286%
-
Price per share
-
$225.50
-
Number of holders
-
178
-
Value change
-
+$193,670,272
-
Number of buys
-
95
-
Number of sells
-
58
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2015
As of 31 Mar 2015,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
178 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,250,632 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, JPMORGAN CHASE & CO, CITIGROUP INC, UBS Group AG, BNP PARIBAS ARBITRAGE, SA, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BARCLAYS PLC.
This page lists
178
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.